Treating head and neck cancer—A multidisciplinary effort
- 01.12.2020
- editorial
Erschienen in:
- Verfasst von
- Gabriele Gamerith, MD
- Assoc. Prof. PD Dr. Thorsten Fuereder
- Erschienen in
- memo - Magazine of European Medical Oncology | Ausgabe 4/2020
Auszug
Head and neck (HNC) is the tenth most common cancer worldwide with over 650,000 new cases per year [1‐3]. The major risk factors for development of squamous cell HNC comprise alcohol and tobacco consumption [4]. During the last few decades human papilloma virus (HPV) infection has been identified to contribute to the development of oropharyngeal HNC in a younger subgroup of patients [5]. This population shows a more favorable prognosis compared to HPV-negative disease [5]. Standard treatment options for HNC independent of HPV status include surgery, standard radiation, chemo- or bioradiation and chemotherapy. …
Anzeige
- Titel
- Treating head and neck cancer—A multidisciplinary effort
- Verfasst von
-
Gabriele Gamerith, MD
Assoc. Prof. PD Dr. Thorsten Fuereder
- Publikationsdatum
- 01.12.2020
- Verlag
- Springer Vienna
- Erschienen in
-
memo - Magazine of European Medical Oncology / Ausgabe 4/2020
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076 - DOI
- https://doi.org/10.1007/s12254-020-00656-3
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.